Immunovant Inc.

IMVT | NASDAQ

Price Alert Chart Builder DCF Calculator

$37.23

+$0.05 (+0.13%)

Sep 22, 2026, 1:28 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2026 Mar 30, 2026	FY 2025 Mar 30, 2025	FY 2024 Mar 30, 2024	FY 2023 Mar 30, 2023	FY 2022 Mar 30, 2022	FY 2021 Mar 30, 2021
Net Income	-505.61M	-413.84M	-259.34M	-210.96M	-156.73M	-107.43M
Depreciation & Amortization	409K	377K	231K	193K	126K	998K
Stock-Based Compensation	55.72M	49.49M	41.12M	32.3M	34.24M	n/a
Other Working Capital	53.72M	-25.69M	1.41M	-5.95M	10.61M	818K
Other Non-Cash Items	99K	133K	1.13M	1.13M	1.11M	18.54M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	42.06M	-12.03M	2.63M	-10.85M	15.14M	4.57M
Operating Cash Flow	-407.31M	-375.87M	-214.23M	-188.19M	-106.11M	-83.33M
Capital Expenditures	-8K	-759K	-360K	-197K	-254K	-210K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-8K	-759K	-360K	-197K	-254K	-210K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	-3.19M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-504K	4.49M	-318K	385K	200M	n/a
Financial Cash Flow	595.76M	454.49M	472.43M	70.89M	200.13M	383.11M
Net Cash Flow	188.14M	78.61M	258.83M	-117.29M	93.67M	299.58M
Free Cash Flow	-407.32M	-376.63M	-214.59M	-188.39M	-106.37M	-83.54M
Adj. Free Cash Flow	-463.04M	-426.12M	-255.7M	-220.69M	-140.61M	-83.54M
Maintenance CapEx	-8K	-377K	-231K	-193K	-126K	-210K
Growth CapEx	n/a	-382K	-129K	-4K	-128K	n/a
Owner Earnings	-407.32M	-376.25M	-214.46M	-188.39M	-106.24M	-83.54M